Calcium handling and ventricular tachyarrhythmias.

Abstract	Pharmacologic modification of cellular calcium handling recently moved into focus as an alternative for prevention and treatment of ventricular tachyarrhythmias. Calcium overload and spontaneous calcium release from the sarcoplasmatic reticulum are regarded as possible initiations of early and delayed afterdepolarization thereby triggering ventricular arrhythmias. In chronic heart failure, calcium overload is more likely to occur compared with healthy hearts, which is one explantation for the increased vulnerability in this condition. L-type calcium channel, sodium-calcium-exchanger (NCX), and ryanodine receptor are crucial for calcium homeostasis and therefore represent potential targets for antiarrhythmic drug therapy. Experimental studies have proven beneficial effects for all these three mechanisms in prevention and suppression of tachyarrhythmias. However, clinical data is mainly available for the L-type calcium channel inhibitor verapamil. Therefore, it is still a long way to clinical employment of drugs modifying cellular calcium handling for antiarrhythmic therapy.
Authors	Gerrit Frommeyer, Lars Eckardt, Peter Milberg
Journal	Wiener medizinische Wochenschrift (1946) (Wien Med Wochenschr) Vol. 162 Issue 13-14 Pg. 283-6 (Jul 2012) ISSN: 1563-258X [Electronic] Austria
PMID	22673935 (Publication Type: Journal Article, Review)
Chemical References	Anti-Arrhythmia Agents Calcium Channels, L-Type Ryanodine Receptor Calcium Release Channel Sodium-Calcium Exchanger Verapamil Calcium
Topics	Animals Anti-Arrhythmia Agents (therapeutic use) Calcium (metabolism) Calcium Channels, L-Type (drug effects, physiology) Electrocardiography Heart Failure (drug therapy, physiopathology) Homeostasis (drug effects, physiology) Humans Myocardial Contraction (drug effects, physiology) Ryanodine Receptor Calcium Release Channel (drug effects, physiology) Sarcoplasmic Reticulum (drug effects, physiology) Sodium-Calcium Exchanger (drug effects, physiology) Tachycardia, Ventricular (drug therapy, physiopathology) Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!